---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026544"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2026-06-01T12:55:34+00:00"
generated_at: "2026-06-01T13:00:26.464320+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

## Summary
- Company will seek strategic acquisition partner for clinical-stage pharma/med-tech operations.
- Stuart D. Porter, founder of Denham Capital (over $12B committed), joins board effective May 29, 2026.
- Strategy targets power equipment/services for hyperscale AI data centers; NERC projects 224 GW demand increase.
- LIXT expects to maintain Nasdaq listing under ticker LIXT during transformation.

## SEC filing metadata
- accession: 0001493152-26-026544
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2026-06-01T12:55:34+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026544
- JSON: https://secwatch.observer/filing/0001493152-26-026544.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026544.txt

## Source-grounded claims
- claim_id: 8f181a2c8a
  claim: Stuart D. Porter was appointed as Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC..
  evidence_excerpt: On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.